These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 554062)

  • 21. [Immunological dtermination of at. III (author's transl)].
    Brogioni M; Biancalani L; Albertazzi M
    Quad Sclavo Diagn; 1976 Sep; 12(3):288-94. PubMed ID: 1025592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of perioperative thromboembolism and antithrombin III levels in patients who are to undergo major gynecologic operations].
    Viceić M; Janković D; Bernat T; Vecek N; Ljubojević N
    Lijec Vjesn; 1988 Nov; 110(11):359-60. PubMed ID: 3231001
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antithrombin III control in patients with long-term anticoagulant therapy].
    Hönig JF; Merten HA; Korth O; Halling F; Köstering H
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):330-3. PubMed ID: 1840095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contraception in the puerperium].
    Litschgi M
    Gynakol Rundsch; 1986; 26 Suppl 1():25-42. PubMed ID: 3792942
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antithrombin-III in preeclampsia-eclampsia. Pilot study].
    Verduzco Rodríguez L; González Puebla E; López Ariza B; Manffrini Madrid F
    Ginecol Obstet Mex; 1998 Aug; 66():343-6. PubMed ID: 9745197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioimmunological determination of prolactin and hormonal correlations in pregnancy at term and in the puerperium].
    Montemagno U; Nappi C; Gravina E
    Arch Ostet Ginecol; 1976; 81(1-3):23-36. PubMed ID: 1052868
    [No Abstract]   [Full Text] [Related]  

  • 28. [The influence of pathological conditions in the second half of gravidity upon lactation (author's transl)].
    Mattová M; Moznerová M
    Cesk Gynekol; 1975 Feb; 40(1):43-4. PubMed ID: 1131899
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pregnancy, oral hormonal contraception and lipid bile composition].
    Dökert B; Jaross W; Schentke KU; Trübsbach A; Sarembe B
    Dtsch Gesundheitsw; 1978; 33(25):1153-5. PubMed ID: 668501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of antithrombin levels in pregnancy.
    James AH; Rhee E; Thames B; Philipp CS
    Thromb Res; 2014 Sep; 134(3):648-51. PubMed ID: 25087890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies of antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Inagaki Y; Setsuda Y
    Rinsho Byori; 1979 Dec; 27(12):1121-5. PubMed ID: 541858
    [No Abstract]   [Full Text] [Related]  

  • 32. [A review of the effects of hormonal contraception on thyroid function (author's transl)].
    L'Hermite M; Hubinont PO
    Rev Fr Gynecol Obstet; 1976 Mar; 71(3):215-9. PubMed ID: 785576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
    Koresawa S; Matsuda N; Ueda S
    Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
    [No Abstract]   [Full Text] [Related]  

  • 34. [A new key to the use of hormonal contraception (author's transl)].
    Berger C
    Schweiz Rundsch Med Prax; 1981 Dec; 70(51):2312-5. PubMed ID: 7329940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the determination of plasma antithrombin III with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Jan; 28(1):81-6. PubMed ID: 7373880
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antithrombin III: the correlation structure-function in healthy people and in cirrhotic patients (author's transl)].
    Vicente JM; Díaz Cremades JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(5):544-53. PubMed ID: 368998
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased thrombin generation in normal pregnancy.
    Pinto S; Abbate R; Rostagno C; Bruni V; Rosati D; Neri Serneri GG
    Acta Eur Fertil; 1988; 19(5):263-7. PubMed ID: 3252655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Latex agglutination method for measurement of antithrombin III in human plasma (author's transl)].
    Fujisawa M; Koyahara I; Yamasaki K; Namba S; Matsuda T; Murakami M
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):898-906. PubMed ID: 7234302
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinogen and its fraction during pregnancy and puerperium.
    Nakamura Y; Abbott R; Hasuo Y; Takeshita T; Nishimura K; Shinagawa S
    Biol Res Pregnancy Perinatol; 1984; 5(3):110-2. PubMed ID: 6478007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.